Keyphrases
Rheumatoid Arthritis
100%
Osteoporotic Fractures
100%
Fracture Risk
100%
Biological Disease-modifying Antirheumatic Drugs (bDMARDs)
100%
Nave
27%
Drug Users
27%
Risk Reduction
18%
Beneficial Effects
18%
Biological Treatment
18%
Denmark
9%
Confidence Interval
9%
Incidence Rate
9%
Population-based
9%
Non-associated
9%
Health Registries
9%
Cox Proportional Hazards Model
9%
Risk Estimates
9%
Forearm
9%
Clinical Trials
9%
Hazard Ratio
9%
Propensity Score
9%
Bone Loss
9%
Humerus
9%
Vertebrae
9%
Fracture Site
9%
New-user Design
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Rheumatoid Arthritis
100%
Fragility Fracture
100%
Disease Modifying Antirheumatic Drug
100%
Clinical Trial
9%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
100%
Cohort Study
100%
Osteolysis
100%
Population Health
100%
Immunology and Microbiology